Articles by Rita Peters - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Rita Peters

Publishing Beyond the Printed Page

Apr 2, 2014

More media options open publishing opportunities for drug development experts.

Defining Quality Metrics is No Easy Task

ISPE and PDA take on the challenge of recommending quality metrics.
Feb 2, 2014

ISPE and PDA take on the challenge of recommending quality metrics.

2014 Manufacturing Trends and Outlook

Single-use systems and other technologies drive process efficiencies, but there is room for improvement.
Jan 15, 2014

A survey of BioPharm International readers found that single-use systems and other technologies are driving process efficiencies in biomanufacturing, but there is room for improvement.

New Dynamics in Drug Pricing and Prescribing

Jan 3, 2014

Generics, market dynamics, and global demand are changing drug-spending patterns.

Drugs At What Cost

Jan 2, 2014

Generics, market dynamics, and global demand are changing drug spending patterns.

Industry Optimism Outweighs Personal Job Security

Restructuring mutes employment optimism.
Dec 2, 2013

Pharmaceutical Technology's 2013 Employment Survey reveals some optimism for the industry's future performance, but ongoing concerns about individual job prospects.

Uncertainty in the Workplace

Industry mergers, acquisitions and downsizing contribute to uncertainty in job security.
Dec 2, 2013

Industry mergers, acquisitions and downsizing contribute to uncertainty in job security in the European bio/pharmaceutical market.

New Funding and Approval Pathways Prove Popular

The JOBS Act and FDASIA show early signs of accelerating drug development.
Nov 2, 2013

The JOBS Act and FDASIA show early signs of accelerating drug development.

Filling a Gap in Drug Safety

As the Supreme Court ruled on generic-drug liability, FDA outlined new rules for warning labels.
Aug 2, 2013

As the Supreme Court ruled on generic-drug liability, FDA outlined new rules for warning labels.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
24%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
15%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here